| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 190.059 | 286.892 | 306.933 | 360.608 |
| Total Income - EUR | - | - | - | - | - | - | 190.059 | 286.892 | 306.934 | 399.464 |
| Total Expenses - EUR | - | - | - | - | - | - | 172.367 | 311.052 | 379.534 | 369.385 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 17.691 | -24.159 | -72.601 | 30.079 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 15.829 | -27.028 | -75.670 | 27.668 |
| Employees | - | - | - | - | - | - | 10 | 13 | 14 | 13 |
Check the financial reports for the company - Emoladal S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 92.678 | 79.955 | 53.471 | 20.972 |
| Current Assets | - | - | - | - | - | - | 8.108 | 1.042 | 1.548 | 4.608 |
| Inventories | - | - | - | - | - | - | 0 | 101 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 859 | 771 | 1.357 | 696 |
| Cash | - | - | - | - | - | - | 7.249 | 169 | 191 | 3.912 |
| Shareholders Funds | - | - | - | - | - | - | 15.869 | -11.110 | -86.746 | -58.594 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 84.917 | 92.107 | 141.765 | 84.174 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5320 - 5320" | |||||||||
| CAEN Financial Year |
5320
|
|||||||||
Comments - Emoladal S.r.l.